NEW research, presented at the European Congress of Radiology 2026, has revealed that white matter hyperintensity progression in cerebral small vessel disease (CSVD) may be closely linked to disturbances in glucose metabolism.
Imaging Insights into CSVD
Radiological markers such as white matter hyperintensities on MRI are widely used to track CSVD disease burden and progression. However, the biological drivers of these imaging changes remain incompletely understood.
Increasing attention has turned to metabolic risk factors that may influence microvascular brain injury. In particular, abnormalities in glucose metabolism are suspected to contribute to vascular and tissue damage within the brain. By combining advanced imaging metrics with metabolic biomarkers, researchers aimed to clarify whether glucometabolic dysregulation plays a causal role in the progression of cerebral small vessel disease.
Machine Learning and Genetic Evidence of Glucose Driven Damage
The study analysed data from 1616 UK Biobank participants of European descent who underwent serial brain MRI scans. Among these individuals, 902 experienced an increase in white matter hyperintensity burden while 714 showed stable findings. Researchers applied seven machine learning algorithms to predict progression, with logistic regression and support vector machine models demonstrating optimal performance.
Eight key predictive features were identified, including age, body mass index, cystatin C, glucose, fractional anisotropy, mean diffusivity, intracellular volume fraction, and isotropic volume fraction. Structural equation modelling revealed that glucose partially mediated white matter hyperintensity progression through isotropic volume fraction, suggesting microstructural tissue damage as an intermediate mechanism.
Genetic analyses further supported this link. Mendelian randomization demonstrated that genetic susceptibility to hemoglobin A1c significantly altered free water content in several white matter tracts, including the left cerebral peduncle, right hippocampal gyrus, left anterior thalamic radiation, and left corticospinal tract.
Implications for Monitoring Disease Progression
These findings suggest that glucometabolic dysregulation may accelerate CSVD progression through subtle microstructural alterations detectable with advanced MRI techniques. Imaging biomarkers may therefore help identify individuals at higher risk of worsening disease.
For radiologists and clinicians, integrating metabolic indicators with imaging features could enhance prediction models and improve early detection of disease progression.
Reference
Han X et al. Glucometabolic dysregulation drives white matter hyperintensity progression in cerebral small vessel disease: longitudinal evidence from the UK biobank and mendelian randomization analysis. ECR, 4-8 March, 2026.
Featured image: Auraclicks on Adobe Stock
